To Order: patrick@cotinis.com
Tcl1 Polyclonal Antibody |
|||
| ABP60647-003ml | Abbkine | 0.03ml | EUR 189.6 |
|
Description: A polyclonal antibody for detection of Tcl1 from Human. This Tcl1 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human Tcl1 protein at amino acid sequence of 30-110 |
|||
Tcl1 Polyclonal Antibody |
|||
| ABP60647-01ml | Abbkine | 0.1ml | EUR 346.8 |
|
Description: A polyclonal antibody for detection of Tcl1 from Human. This Tcl1 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human Tcl1 protein at amino acid sequence of 30-110 |
|||
Tcl1 Polyclonal Antibody |
|||
| ABP60647-02ml | Abbkine | 0.2ml | EUR 496.8 |
|
Description: A polyclonal antibody for detection of Tcl1 from Human. This Tcl1 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human Tcl1 protein at amino acid sequence of 30-110 |
|||
Tcl1 Polyclonal Conjugated Antibody |
|||
| C46760 | SAB | 100ul | EUR 476.4 |
TCL1 antibody |
|||
| 10R-6614 | Fitzgerald | 100 ug | EUR 528 |
|
Description: Mouse monoclonal TCL1 antibody |
|||
Tcl1 Antibody |
|||
| abx431644-200ul | Abbexa | 200 ul | EUR 343.2 |
TCL1 Antibody |
|||
| R35369-100UG | NSJ Bioreagents | 100 ug | EUR 399 |
TCL1 Antibody |
|||
| V3936-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: Enhances the phosphorylation and activation of AKT1, AKT2 and AKT3. Promotes nuclear translocation of AKT1. Enhances cell proliferation, stabilizes mitochondrial membrane potential and promotes cell survival. [UniProt] |
|||
TCL1 Antibody |
|||
| V3936-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: Enhances the phosphorylation and activation of AKT1, AKT2 and AKT3. Promotes nuclear translocation of AKT1. Enhances cell proliferation, stabilizes mitochondrial membrane potential and promotes cell survival. [UniProt] |
|||
TCL1 Antibody |
|||
| V3936SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: Enhances the phosphorylation and activation of AKT1, AKT2 and AKT3. Promotes nuclear translocation of AKT1. Enhances cell proliferation, stabilizes mitochondrial membrane potential and promotes cell survival. [UniProt] |
|||
TCL1 Antibody |
|||
| V3960-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: T-cell leukemia/Lymphoma Protein 1A (TCL-1A), also known as p14TCL1 is a product of the TCL1 gene that is involved in T-cell prolymphocytic leukemia (TPLL). T-PLL is a rare form of mature T-cell leukemia, which is consistently associated with chromosomal rearrangements characterized by the juxtaposition of the TCRA locus on chromosome 14q11 and the TCL1A gene on 14q32.13. TCL1 is overexpressed in Burkitt lymphoma, the majority of AIDS-related non-Hodgkin lymphoma-designated immunoblastic plasmacytoid lymphoma, lymphoblastic lymphoma, chronic lymphocytic leukemia, mantle cell lymphoma, follicular lymphoma, diffuse large B-cell lymphoma, and primary cutaneous B-cell lymphoma. |
|||
TCL1 Antibody |
|||
| V3960-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: T-cell leukemia/Lymphoma Protein 1A (TCL-1A), also known as p14TCL1 is a product of the TCL1 gene that is involved in T-cell prolymphocytic leukemia (TPLL). T-PLL is a rare form of mature T-cell leukemia, which is consistently associated with chromosomal rearrangements characterized by the juxtaposition of the TCRA locus on chromosome 14q11 and the TCL1A gene on 14q32.13. TCL1 is overexpressed in Burkitt lymphoma, the majority of AIDS-related non-Hodgkin lymphoma-designated immunoblastic plasmacytoid lymphoma, lymphoblastic lymphoma, chronic lymphocytic leukemia, mantle cell lymphoma, follicular lymphoma, diffuse large B-cell lymphoma, and primary cutaneous B-cell lymphoma. |
|||
TCL1 Antibody |
|||
| V3960SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: T-cell leukemia/Lymphoma Protein 1A (TCL-1A), also known as p14TCL1 is a product of the TCL1 gene that is involved in T-cell prolymphocytic leukemia (TPLL). T-PLL is a rare form of mature T-cell leukemia, which is consistently associated with chromosomal rearrangements characterized by the juxtaposition of the TCRA locus on chromosome 14q11 and the TCL1A gene on 14q32.13. TCL1 is overexpressed in Burkitt lymphoma, the majority of AIDS-related non-Hodgkin lymphoma-designated immunoblastic plasmacytoid lymphoma, lymphoblastic lymphoma, chronic lymphocytic leukemia, mantle cell lymphoma, follicular lymphoma, diffuse large B-cell lymphoma, and primary cutaneous B-cell lymphoma. |
|||
TCL1 Antibody |
|||
| V7368-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: T-cell leukemia/Lymphoma Protein 1A (TCL-1A), also known as p14TCL1 is a product of the TCL1 gene that is involved in T-cell prolymphocytic leukemia (TPLL). T-PLL is a rare form of mature T-cell leukemia, which is consistently associated with chromosomal rearrangements characterized by the juxtaposition of the TCRA locus on chromosome 14q11 and the TCL1A gene on 14q32.13. TCL1 is overexpressed in Burkitt lymphoma, the majority of AIDS-related non-Hodgkin lymphoma-designated immunoblastic plasmacytoid lymphoma, lymphoblastic lymphoma, chronic lymphocytic leukemia, mantle cell lymphoma, follicular lymphoma, diffuse large B-cell lymphoma, and primary cutaneous B-cell lymphoma. |
|||
TCL1 Antibody |
|||
| V7368-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: T-cell leukemia/Lymphoma Protein 1A (TCL-1A), also known as p14TCL1 is a product of the TCL1 gene that is involved in T-cell prolymphocytic leukemia (TPLL). T-PLL is a rare form of mature T-cell leukemia, which is consistently associated with chromosomal rearrangements characterized by the juxtaposition of the TCRA locus on chromosome 14q11 and the TCL1A gene on 14q32.13. TCL1 is overexpressed in Burkitt lymphoma, the majority of AIDS-related non-Hodgkin lymphoma-designated immunoblastic plasmacytoid lymphoma, lymphoblastic lymphoma, chronic lymphocytic leukemia, mantle cell lymphoma, follicular lymphoma, diffuse large B-cell lymphoma, and primary cutaneous B-cell lymphoma. |
|||
TCL1 Antibody |
|||
| V7368IHC-7ML | NSJ Bioreagents | 7 ml | EUR 499 |
|
Description: T-cell leukemia/Lymphoma Protein 1A (TCL-1A), also known as p14TCL1 is a product of the TCL1 gene that is involved in T-cell prolymphocytic leukemia (TPLL). T-PLL is a rare form of mature T-cell leukemia, which is consistently associated with chromosomal rearrangements characterized by the juxtaposition of the TCRA locus on chromosome 14q11 and the TCL1A gene on 14q32.13. TCL1 is overexpressed in Burkitt lymphoma, the majority of AIDS-related non-Hodgkin lymphoma-designated immunoblastic plasmacytoid lymphoma, lymphoblastic lymphoma, chronic lymphocytic leukemia, mantle cell lymphoma, follicular lymphoma, diffuse large B-cell lymphoma, and primary cutaneous B-cell lymphoma. |
|||
TCL1 Antibody |
|||
| V7368SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: T-cell leukemia/Lymphoma Protein 1A (TCL-1A), also known as p14TCL1 is a product of the TCL1 gene that is involved in T-cell prolymphocytic leukemia (TPLL). T-PLL is a rare form of mature T-cell leukemia, which is consistently associated with chromosomal rearrangements characterized by the juxtaposition of the TCRA locus on chromosome 14q11 and the TCL1A gene on 14q32.13. TCL1 is overexpressed in Burkitt lymphoma, the majority of AIDS-related non-Hodgkin lymphoma-designated immunoblastic plasmacytoid lymphoma, lymphoblastic lymphoma, chronic lymphocytic leukemia, mantle cell lymphoma, follicular lymphoma, diffuse large B-cell lymphoma, and primary cutaneous B-cell lymphoma. |
|||
TCL1 Antibody |
|||
| V7369-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: T-cell leukemia/Lymphoma Protein 1A (TCL-1A), also known as p14TCL1 is a product of the TCL1 gene that is involved in T-cell prolymphocytic leukemia (TPLL). T-PLL is a rare form of mature T-cell leukemia, which is consistently associated with chromosomal rearrangements characterized by the juxtaposition of the TCRA locus on chromosome 14q11 and the TCL1A gene on 14q32.13. TCL1 is overexpressed in Burkitt lymphoma, the majority of AIDS-related non-Hodgkin lymphoma-designated immunoblastic plasmacytoid lymphoma, lymphoblastic lymphoma, chronic lymphocytic leukemia, mantle cell lymphoma, follicular lymphoma, diffuse large B-cell lymphoma, and primary cutaneous B-cell lymphoma. |
|||
TCL1 Antibody |
|||
| V7369-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: T-cell leukemia/Lymphoma Protein 1A (TCL-1A), also known as p14TCL1 is a product of the TCL1 gene that is involved in T-cell prolymphocytic leukemia (TPLL). T-PLL is a rare form of mature T-cell leukemia, which is consistently associated with chromosomal rearrangements characterized by the juxtaposition of the TCRA locus on chromosome 14q11 and the TCL1A gene on 14q32.13. TCL1 is overexpressed in Burkitt lymphoma, the majority of AIDS-related non-Hodgkin lymphoma-designated immunoblastic plasmacytoid lymphoma, lymphoblastic lymphoma, chronic lymphocytic leukemia, mantle cell lymphoma, follicular lymphoma, diffuse large B-cell lymphoma, and primary cutaneous B-cell lymphoma. |
|||
TCL1 Antibody |
|||
| V7369IHC-7ML | NSJ Bioreagents | 7 ml | EUR 499 |
|
Description: T-cell leukemia/Lymphoma Protein 1A (TCL-1A), also known as p14TCL1 is a product of the TCL1 gene that is involved in T-cell prolymphocytic leukemia (TPLL). T-PLL is a rare form of mature T-cell leukemia, which is consistently associated with chromosomal rearrangements characterized by the juxtaposition of the TCRA locus on chromosome 14q11 and the TCL1A gene on 14q32.13. TCL1 is overexpressed in Burkitt lymphoma, the majority of AIDS-related non-Hodgkin lymphoma-designated immunoblastic plasmacytoid lymphoma, lymphoblastic lymphoma, chronic lymphocytic leukemia, mantle cell lymphoma, follicular lymphoma, diffuse large B-cell lymphoma, and primary cutaneous B-cell lymphoma. |
|||
TCL1 Antibody |
|||
| V7369SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: T-cell leukemia/Lymphoma Protein 1A (TCL-1A), also known as p14TCL1 is a product of the TCL1 gene that is involved in T-cell prolymphocytic leukemia (TPLL). T-PLL is a rare form of mature T-cell leukemia, which is consistently associated with chromosomal rearrangements characterized by the juxtaposition of the TCRA locus on chromosome 14q11 and the TCL1A gene on 14q32.13. TCL1 is overexpressed in Burkitt lymphoma, the majority of AIDS-related non-Hodgkin lymphoma-designated immunoblastic plasmacytoid lymphoma, lymphoblastic lymphoma, chronic lymphocytic leukemia, mantle cell lymphoma, follicular lymphoma, diffuse large B-cell lymphoma, and primary cutaneous B-cell lymphoma. |
|||
TCL1 |
|||
| TCL1A-100T | ImmunoStep | 100 test | EUR 949.2 |
TCL1 (T-Cell Marker) (TCL1/2078) Antibody |
|||
| BNC942078-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against TCL1 (T-Cell Marker) (TCL1/2078), CF594 conjugate, Concentration: 0.1mg/mL |
|||
TCL1 (T-Cell Marker) (TCL1/2078) Antibody |
|||
| BNC942078-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against TCL1 (T-Cell Marker) (TCL1/2078), CF594 conjugate, Concentration: 0.1mg/mL |
|||
TCL1 (T-Cell Marker) (TCL1/2747R) Antibody |
|||
| BNC942747-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against TCL1 (T-Cell Marker) (TCL1/2747R), CF594 conjugate, Concentration: 0.1mg/mL |
|||
TCL1 (T-Cell Marker) (TCL1/2747R) Antibody |
|||
| BNC942747-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against TCL1 (T-Cell Marker) (TCL1/2747R), CF594 conjugate, Concentration: 0.1mg/mL |
|||
TCL1 (T-Cell Marker) (TCL1/2078) Antibody |
|||
| BNCA2078-250 | Biotium | 250uL | EUR 472.8 |
|
Description: Primary antibody against TCL1 (T-Cell Marker) (TCL1/2078), APC conjugate, Concentration: 0.1mg/mL |
|||
TCL1 (T-Cell Marker) (TCL1/2747R) Antibody |
|||
| BNCA2747-250 | Biotium | 250uL | EUR 472.8 |
|
Description: Primary antibody against TCL1 (T-Cell Marker) (TCL1/2747R), APC conjugate, Concentration: 0.1mg/mL |
|||
TCL1 (T-Cell Marker) (TCL1/2078) Antibody |
|||
| BNC552078-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against TCL1 (T-Cell Marker) (TCL1/2078), CF555 conjugate, Concentration: 0.1mg/mL |
|||
TCL1 (T-Cell Marker) (TCL1/2078) Antibody |
|||
| BNC552078-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against TCL1 (T-Cell Marker) (TCL1/2078), CF555 conjugate, Concentration: 0.1mg/mL |
|||
TCL1 (T-Cell Marker) (TCL1/2747R) Antibody |
|||
| BNC552747-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against TCL1 (T-Cell Marker) (TCL1/2747R), CF555 conjugate, Concentration: 0.1mg/mL |
|||
TCL1 (T-Cell Marker) (TCL1/2747R) Antibody |
|||
| BNC552747-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against TCL1 (T-Cell Marker) (TCL1/2747R), CF555 conjugate, Concentration: 0.1mg/mL |
|||
TCL1 (T-Cell Marker) (TCL1/2078) Antibody |
|||
| BNC612078-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against TCL1 (T-Cell Marker) (TCL1/2078), CF660R conjugate, Concentration: 0.1mg/mL |
|||
TCL1 (T-Cell Marker) (TCL1/2078) Antibody |
|||
| BNC612078-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against TCL1 (T-Cell Marker) (TCL1/2078), CF660R conjugate, Concentration: 0.1mg/mL |
|||
TCL1 (T-Cell Marker) (TCL1/2747R) Antibody |
|||
| BNC612747-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against TCL1 (T-Cell Marker) (TCL1/2747R), CF660R conjugate, Concentration: 0.1mg/mL |
|||
TCL1 (T-Cell Marker) (TCL1/2747R) Antibody |
|||
| BNC612747-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against TCL1 (T-Cell Marker) (TCL1/2747R), CF660R conjugate, Concentration: 0.1mg/mL |
|||
TCL1 (T-Cell Marker) (TCL1/2078) Antibody |
|||
| BNCP2078-250 | Biotium | 250uL | EUR 472.8 |
|
Description: Primary antibody against TCL1 (T-Cell Marker) (TCL1/2078), PerCP conjugate, Concentration: 0.1mg/mL |
|||
TCL1 (T-Cell Marker) (TCL1/2747R) Antibody |
|||
| BNCP2747-250 | Biotium | 250uL | EUR 472.8 |
|
Description: Primary antibody against TCL1 (T-Cell Marker) (TCL1/2747R), PerCP conjugate, Concentration: 0.1mg/mL |
|||
TCL1 (T-Cell Marker) (TCL1/2078) Antibody |
|||
| BNCR2078-250 | Biotium | 250uL | EUR 472.8 |
|
Description: Primary antibody against TCL1 (T-Cell Marker) (TCL1/2078), RPE conjugate, Concentration: 0.1mg/mL |
|||
TCL1 (T-Cell Marker) (TCL1/2747R) Antibody |
|||
| BNCR2747-250 | Biotium | 250uL | EUR 472.8 |
|
Description: Primary antibody against TCL1 (T-Cell Marker) (TCL1/2747R), RPE conjugate, Concentration: 0.1mg/mL |
|||
TCL1 (T-Cell Marker) (TCL1/2078) Antibody |
|||
| BNC402078-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against TCL1 (T-Cell Marker) (TCL1/2078), CF640R conjugate, Concentration: 0.1mg/mL |
|||
TCL1 (T-Cell Marker) (TCL1/2078) Antibody |
|||
| BNC402078-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against TCL1 (T-Cell Marker) (TCL1/2078), CF640R conjugate, Concentration: 0.1mg/mL |
|||